IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD138 Test
Test Name: IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD138 Test
Components: CD138
Price: 480.0 AED
Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube and 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube or 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date, and clinical details on the test request form.
Report Delivery: Sample Daily by 9 am; Report Same day
Method: Flow Cytometry
Test type: Cancer
Doctor: Hematologist, Oncologist
Test Department: FLOW CYTOMETRY
Pre Test Information: Give brief clinical history.
Test Details: CD138 is a cell surface glycoprotein that is commonly used as a marker for plasma cells. Immunophenotyping by flow cytometry with CD138 antibody allows for the identification and enumeration of plasma cells in a sample. To perform the CD138 test, a sample containing cells of interest (such as peripheral blood, bone marrow, or tissue) is first prepared. The cells are then stained with a fluorescently labeled CD138 antibody. This antibody specifically binds to CD138 on the surface of plasma cells. After staining, the sample is analyzed using a flow cytometer. The flow cytometer uses laser beams to detect and measure the fluorescence emitted by the labeled cells. By comparing the fluorescence intensity of the stained cells to unstained cells or cells stained with an isotype control antibody, the presence and quantity of CD138-positive plasma cells can be determined. The results of the CD138 test can provide valuable information about the presence and distribution of plasma cells in various disease states, such as multiple myeloma, Waldenstrom macroglobulinemia, and other plasma cell disorders. It can also be used to monitor treatment response and disease progression. Overall, immunophenotyping by flow cytometry with CD138 is a useful tool in the diagnosis and monitoring of plasma cell-related disorders.
| Test Name | IMMUNOPHENOTYPING BY FLOW CYTOMETRY CD138 Test |
|---|---|
| Components | |
| Price | 480.0 AED |
| Sample Condition | 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone marrow in 1 Green Top (Sodium heparin) tube. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on test request form. |
| Report Delivery | Sample Daily by 9 am; Report Same day |
| Method | Flow Cytometry |
| Test type | Cancer |
| Doctor | Hematologist, Oncologist |
| Test Department: | FLOW CYTOMETRY |
| Pre Test Information | Give brief clinical history. |
| Test Details |
CD138 is a cell surface glycoprotein that is commonly used as a marker for plasma cells. Immunophenotyping by flow cytometry with CD138 antibody allows for the identification and enumeration of plasma cells in a sample. To perform the CD138 test, a sample containing cells of interest (such as peripheral blood, bone marrow, or tissue) is first prepared. The cells are then stained with a fluorescently labeled CD138 antibody. This antibody specifically binds to CD138 on the surface of plasma cells. After staining, the sample is analyzed using a flow cytometer. The flow cytometer uses laser beams to detect and measure the fluorescence emitted by the labeled cells. By comparing the fluorescence intensity of the stained cells to unstained cells or cells stained with an isotype control antibody, the presence and quantity of CD138-positive plasma cells can be determined. The results of the CD138 test can provide valuable information about the presence and distribution of plasma cells in various disease states, such as multiple myeloma, Waldenstrom macroglobulinemia, and other plasma cell disorders. It can also be used to monitor treatment response and disease progression. Overall, immunophenotyping by flow cytometry with CD138 is a useful tool in the diagnosis and monitoring of plasma cell-related disorders. |
